MSF calls on governments to support landmark move at WTO to suspend patents during COVID-19

MSF and supporters protest in front of the European Patent Office in September 2018 to demand no patents on the hepatitis C drug sofosbuvir. MSF has a long history of calling for the production of affordable, generic versions of medicines. Many generic medications—including those MSF uses in its projects worldwide—are produced in India, which is often referred to as the "pharmacy of the developing world."